64,95 €
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
32 °P sammeln
64,95 €
64,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
32 °P sammeln
Als Download kaufen
64,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
32 °P sammeln
Jetzt verschenken
64,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
32 °P sammeln
  • Format: PDF

Covers all the recent developments in peritoneal surface oncology
Includes the basics of CRS and HIPEC like patient selection, surgical technique, HIPEC methodologies
Covers individual diseases with an update on the recent developments
Offers practical suggestions and tips at the end of each chapter

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 13.59MB
Produktbeschreibung
Covers all the recent developments in peritoneal surface oncology

Includes the basics of CRS and HIPEC like patient selection, surgical technique, HIPEC methodologies

Covers individual diseases with an update on the recent developments

Offers practical suggestions and tips at the end of each chapter


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
''Dr. Aditi Bhatt is a Surgical oncologist specializing in the management of peritoneal surface malignancies. She has done her surgical oncology training from the Gujarat Cancer Research Institute in Ahmedabad, India and has further pursued a fellowship in peritoneal surface malignancies at Institut Gustave Roussy, Paris, France. She has been pursuing peritoneal surface oncology as a speciality for seven years. She was associate editor with Dr. Paul H. Sugarbaker for the special issue of the Indian Journal of Surgical Oncology on peritoneal surface malignancies in 2016. Dr. Aditi is currently involved in developing a robust system for collection and publication of Indian data pertaining to the management of peritoneal metastases and conducting multi-institutional studies.  Here specific areas of interest are pseudomyoma peritonei and other rare peritoneal tumors and ovarian cancer.'